NexGen Medical Systems, Inc

Launching a next-generation medical device, XCOIL(TM), that removes soft and hard clots from veins and arteries without using lytic drugs.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Seattle, WA, US
  • Currency USD
  • Founded April 2004
  • Employees 3
  • Incorporation Type C-corp
  • Website xcoil.net

Company Summary

We sell our FDA-cleared XCOIL(TM) thrombectomy device for deep vein thrombosis (DVT), and will apply it to stroke and pulmonary embolism. XCOIL(TM) is unique, removing both soft (acute) and hard (chronic) clots, without lytic drugs. Rapid clot removal, possible only with a device, is critical for long-term function. The markets are growing rapidly.
The plan is to become cashflow positive by the end of year 3. Likely liquidity is acquisition.

Team

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free